The 69 rating InvestorsObserver gives to CASI Pharmaceuticals Inc (CASI) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 81 percent of stocks in the Biotechnology industry, CASI’s 69 overall rating means the stock scores better than 69 percent of all stocks.
CASI has an Overall Score of 69. Find out what this means to you and get the rest of the rankings on CASI!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With CASI Pharmaceuticals Inc Stock Today?
CASI Pharmaceuticals Inc (CASI) stock is trading at $2.69 as of 11:29 AM on Monday, May 15, a rise of $0.17, or 6.75% from the previous closing price of $2.52. The stock has traded between $2.48 and $2.69 so far today. Volume today is below average. So far 15,462 shares have traded compared to average volume of 34,823 shares.
Click Here to get the full Stock Report for CASI Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
